Fichtner I - Search Results

1

Sagopilone crosses the blood-brain barrier in vivo to inhibit brain tumor growth and metastases.

Hoffmann J, Fichtner I, Lemm M, Lienau P, Hess-Stumpp H, Rotgeri A, Hofmann B, Klar U. Hoffmann J, et al. Among authors: fichtner i. Neuro Oncol. 2009 Apr;11(2):158-66. doi: 10.1215/15228517-2008-072. Epub 2008 Sep 9. Neuro Oncol. 2009. PMID: 18780814 Free PMC article.

2

Comparative profiling of the novel epothilone, sagopilone, in xenografts derived from primary non-small cell lung cancer.

Hammer S, Sommer A, Fichtner I, Becker M, Rolff J, Merk J, Klar U, Hoffmann J. Hammer S, et al. Among authors: fichtner i. Clin Cancer Res. 2010 Mar 1;16(5):1452-65. doi: 10.1158/1078-0432.CCR-09-2455. Epub 2010 Feb 23. Clin Cancer Res. 2010. PMID: 20179216

3

Efficacy of MS-275, a selective inhibitor of class I histone deacetylases, in human colon cancer models.

Bracker TU, Sommer A, Fichtner I, Faus H, Haendler B, Hess-Stumpp H. Bracker TU, et al. Among authors: fichtner i. Int J Oncol. 2009 Oct;35(4):909-20. doi: 10.3892/ijo_00000406. Int J Oncol. 2009. PMID: 19724929

4

Treatment with 5-azacitidine delay growth of glioblastoma xenografts: a potential new treatment approach for glioblastomas.

Kratzsch T, Kuhn SA, Joedicke A, Hanisch UK, Vajkoczy P, Hoffmann J, Fichtner I. Kratzsch T, et al. Among authors: fichtner i. J Cancer Res Clin Oncol. 2018 May;144(5):809-819. doi: 10.1007/s00432-018-2600-1. Epub 2018 Feb 9. J Cancer Res Clin Oncol. 2018. PMID: 29427211

5

Preclinical Study of a Combination of Erlotinib and Bevacizumab in Early Stages of Unselected Non-Small Cell Lung Cancer Patient-Derived Xenografts.

Rolff J, Becker M, Merk J, Hoffmann J, Fichtner I. Rolff J, et al. Among authors: fichtner i. Target Oncol. 2016 Aug;11(4):507-14. doi: 10.1007/s11523-015-0415-4. Target Oncol. 2016. PMID: 26817645

6

Preclinical study on combined chemo- and nonviral gene therapy for sensitization of melanoma using a human TNF-alpha expressing MIDGE DNA vector.

Kobelt D, Aumann J, Schmidt M, Wittig B, Fichtner I, Behrens D, Lemm M, Freundt G, Schlag PM, Walther W. Kobelt D, et al. Among authors: fichtner i. Mol Oncol. 2014 May;8(3):609-19. doi: 10.1016/j.molonc.2013.12.019. Epub 2014 Jan 18. Mol Oncol. 2014. PMID: 24503218 Free PMC article.

7

Effects of amifostine (WR-2721, ethyol) on tumor growth and pharmacology of cytotoxic drugs in human xenotransplanted neuroblastomas.

Fichtner I, Lemm M, Becker M, Berthold F. Fichtner I, et al. Anticancer Drugs. 1997 Feb;8(2):174-81. doi: 10.1097/00001813-199702000-00008. Anticancer Drugs. 1997. PMID: 9073313

8

Development of a mitoxantrone-resistant P 388 in vivo: approaches to overcome resistance.

Fichtner I, Becker M, Lemm M, Winterfeld G. Fichtner I, et al. Oncology. 1990;47(6):508-15. doi: 10.1159/000226881. Oncology. 1990. PMID: 1700851

9

Treatment of experimental brain metastasis with MTO-liposomes: impact of fluidity and LRP-targeting on the therapeutic result.

Orthmann A, Zeisig R, Süss R, Lorenz D, Lemm M, Fichtner I. Orthmann A, et al. Among authors: fichtner i. Pharm Res. 2012 Jul;29(7):1949-59. doi: 10.1007/s11095-012-0723-7. Epub 2012 Mar 8. Pharm Res. 2012. PMID: 22399388

10

Establishment of patient-derived non-small cell lung cancer xenografts as models for the identification of predictive biomarkers.

Fichtner I, Rolff J, Soong R, Hoffmann J, Hammer S, Sommer A, Becker M, Merk J. Fichtner I, et al. Clin Cancer Res. 2008 Oct 15;14(20):6456-68. doi: 10.1158/1078-0432.CCR-08-0138. Clin Cancer Res. 2008. PMID: 18927285 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

228 results

Search Page

Filters